Cargando…

Iron Overload in Sickle Cell Disease

In sickle cell disease transfusions improve blood flow by reducing the proportion of red cells capable of forming sickle hemoglobin polymer. This limits hemolysis and the endothelial damage that result from high proportions of sickle polymer-containing red cells. Additionally, transfusions are used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raghupathy, Radha, Manwani, Deepa, Little, Jane A.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872757/ https://www.ncbi.nlm.nih.gov/pubmed/20490352 http://dx.doi.org/10.1155/2010/272940

Ejemplares similares

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2020)

Iron Status in Sickle Cell Anemia: Deficiency or Overload?
por: Patel, Varsha P, et al.
Publicado: (2023)

GSTM1 and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload
por: Puri, Latika, et al.
Publicado: (2019)

Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature
por: Hoogenboom, Wouter S., et al.
Publicado: (2022)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

Mycobacterium avium Complex Infection in a Patient with Sickle Cell Disease and Severe Iron Overload
por: Shemisa, Kamal, et al.
Publicado: (2014)

2396. Clostridium difficile Infection is Children with Sickle Cell Disease: An Uncommon Entity
por: Lee, Philip, et al.
Publicado: (2019)

Emerging disease-modifying therapies for sickle cell disease
por: Carden, Marcus A., et al.
Publicado: (2019)

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
por: Vichinsky, Elliott, et al.
Publicado: (2007)

Chronic red cell exchange in sickle cell patients with iron overload may not affect mortality
por: Zhou, Yi Yuan, et al.
Publicado: (2022)

The Role of Iron and Iron Overload in Chronic Liver Disease
por: Milic, Sandra, et al.
Publicado: (2016)

Iron overload disorders
por: Hsu, Christine C., et al.
Publicado: (2022)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
por: de Montalembert, Mariane, et al.
Publicado: (2017)

PI-01: GRNDAD AND COUSIN: INVESTIGATOR-INITIATED COLLABORATIONS TO IMPROVE CARE IN SICKLE CELL DISEASE
por: J., LITTLE, et al.
Publicado: (2022)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Deferasirox versus deferoxamine in managing iron overload in patients with Sickle Cell Anaemia: a systematic review and meta-analysis
por: Qadah, Talal
Publicado: (2022)

Burden of iron overload among non-chronically blood transfused preschool children with sickle cell anaemia
por: Olufemi, Akodu Samuel, et al.
Publicado: (2021)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

Iron Metabolism in Thalassemia and Sickle Cell Disease.
por: Mariani, Raffaella, et al.
Publicado: (2009)

What is new in iron overload?
por: Vermylen, Christiane
Publicado: (2007)

Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - a fifteen hospital observational study in the Bronx, New York
por: Hoogenboom, Wouter S., et al.
Publicado: (2021)

Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation
por: Stanley, Helen M., et al.
Publicado: (2016)

Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia
por: Barbosa, Maritza Cavalcante, et al.
Publicado: (2013)

Ambulatory Hypertension in Pediatric Patients With Sickle Cell Disease and Its Association With End-Organ Damage
por: Ranabothu, Saritha, et al.
Publicado: (2020)

Long-term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease
por: Vichinsky, Elliott, et al.
Publicado: (2011)

Study of Adrenal Functions using ACTH stimulation test in Egyptian children with Sickle Cell Anemia: Correlation with Iron Overload
por: A Hagag, Adel, et al.
Publicado: (2015)

Altered parasite life-cycle processes characterize Babesia divergens infection in human sickle cell anemia
por: Cursino-Santos, Jeny R., et al.
Publicado: (2019)

Novel Insights into Alcoholic Liver Disease: Iron Overload, Iron Sensing and Hemolysis
por: Mueller, Sebastian, et al.
Publicado: (2022)

Effect of Hereditary Hemochromatosis Gene H63D and C282Y Mutations on Iron Overload in Sickle Cell Disease Patients
por: Terzi, Yunus Kasım, et al.
Publicado: (2016)

Prooxidant Mechanisms in Iron Overload Cardiomyopathy
por: Cheng, Ching-Feng, et al.
Publicado: (2013)

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2022)

Very low incidence of Clostridioides difficile infection in pediatric sickle cell disease patients
por: Lee, Philip, et al.
Publicado: (2020)

Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
por: Breda, Laura, et al.
Publicado: (2012)

Blood transfusion and iron overload in patients with Sickle Cell Disease (SCD): Personal experience and a short update of diabetes mellitus occurrence
por: Soliman, Ashraf T, et al.
Publicado: (2022)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Comments on: "Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia"
por: Driss, Adel
Publicado: (2013)

Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells
por: Tolu, Seda S., et al.
Publicado: (2020)

HbF Levels in Sickle Cell Disease Are Associated with Proportion of Circulating Hematopoietic Stem and Progenitor Cells and CC-Chemokines
por: Minniti, Caterina P., et al.
Publicado: (2020)

Treatment patterns and burden of complications associated with sickle cell disease: A US retrospective claims analysis
por: Manwani, Deepa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ms975903uo53reg4f6vtksqign